立即開始
Audacity618

$8 target (Short term)

看多
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)  
Audacity618  
NASDAQ:MACK   Merrimack Pharmaceuticals, Inc.
0
0
Broke the .236 retracement and soon to re-test $6.50. Bullish crosses on 50,100,200. Trial update in Q2 for Phase 3 MM-398. Position: 4,200 shares @4.82
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。